Baolingbao Biology Co.,Ltd. (SHE:002286)

China flag China · Delayed Price · Currency is CNY
10.63
+0.07 (0.66%)
Mar 9, 2026, 3:04 PM CST
45.02%
Market Cap 4.05B
Revenue (ttm) 2.69B
Net Income (ttm) 144.09M
Shares Out 380.57M
EPS (ttm) 0.39
PE Ratio 27.22
Forward PE n/a
Dividend 0.12 (1.14%)
Ex-Dividend Date Jul 3, 2025
Volume 16,130,280
Average Volume 21,598,033
Open 10.01
Previous Close 10.56
Day's Range 10.01 - 10.74
52-Week Range 6.45 - 13.40
Beta 0.53
RSI 54.63
Earnings Date Apr 25, 2026

About Baolingbao Biology

Baolingbao Biology Co.,Ltd. researches and develops, manufactures, and sells a range of functional sugars in China. The company offers prebiotics, such as isomaltooligosaccharides, galactooligosaccharides, fructooligosaccharides, bagasse trisaccharides, and xylooligosaccharides; sugar alcohols and new sugar source products, including erythritol, trehalose, crystalline fructose, alodonose, and maltose; dietary fiber products comprising polydextrose and resistant dextrin; modified, waxy maize, and corn starch products; starch sugar products, incl... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1997
Employees 1,395
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002286
Full Company Profile

Financial Performance

In 2024, Baolingbao Biology's revenue was 2.40 billion, a decrease of -4.84% compared to the previous year's 2.52 billion. Earnings were 111.16 million, an increase of 105.97%.

Financial Statements

News

There is no news available yet.